Chapter

Renin-Angiotensin System in the Kidney and Oxidative Stress: Local Renin-Angiotensin-Aldosterone System and NADPH Oxidase-Dependent Oxidative Stress in the Kidney

12/2010; DOI:10.1007/978-1-60761-857-7_4 pp.71-91

ABSTRACT The renin-angiotensin system (RAS) plays an important role in the pathogenesis of renal diseases. All of the RAS components
can be found in the kidney, and intrarenal angiotensin II (AngII) is formed by multiple independent mechanisms. There is also
increasing evidence implicating aldosterone as an important factor besides AngII in the pathogenesis of renal diseases. Therefore,
we should include aldosterone as one of the key components of the renin-angiotensin-aldosterone system (RAAS) when trying
to understand how renal diseases are induced and augmented and, in turn, how they can be suppressed. Although multiple pathways
are involved in the RAAS-dependent renal injury, there is increasing evidence supporting the roles of reactive oxygen species
(ROS), which contribute to renal functional aberrations and pro-inflammatory or pro-fibrotic tissue damages. Animal studies
have shown that AngII- and aldosterone-dependent renal injury is associated with increased ROS production and nicotinamide
adenine dinucleotide phosphate (NADPH) oxidase activity. Furthermore, preclinical and clinical studies have indicated that
the reno-protective effects of RAAS inhibitors are associated with their antioxidative effects. In this chapter, we will briefly
summarize our current understanding of the role of ROS in mediating RAAS-dependent renal injury with special emphasis on the
role of NADPH oxidase.

KeywordsReactive oxygen species-NADPH oxidase-RAAS blockade

0 0
 · 
0 Bookmarks
 · 
21 Views

Keywords

aldosterone-dependent renal injury
 
AngII-
 
Animal studies
 
clinical studies
 
current understanding
 
evidence implicating aldosterone
 
intrarenal angiotensin II
 
key components
 
KeywordsReactive oxygen species-NADPH oxidase-RAAS blockade
 
mediating RAAS-dependent renal injury
 
multiple independent mechanisms
 
pro-fibrotic tissue damages
 
RAAS inhibitors
 
RAAS-dependent renal injury
 
RAS components
 
renal diseases
 
renal functional aberrations
 
renin-angiotensin system
 
renin-angiotensin-aldosterone system
 
special emphasis